From: Low-dose lymphocyte immunotherapy rebalances the peripheral blood Th1/Th2/Treg paradigm in patients with unexplained recurrent miscarriage
Control Group
Immunotherapy Group
p value
Pregnancy
23(23/35)
43(43/64)
Delivery
14(60.87%)
32(74.42%)
0.068
≥20 weeks
1(4.35%)
5(11.63%)
–
Exfetation
0(0.00%)
1(2.32%)
Abortion
8(34.78%)
0.048